{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:15:10Z","timestamp":1793103310061,"version":"4.5.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fatty liver disease (FLD) is increasingly common in the general population, yet risk stratification in routine health examinations still relies heavily on body mass index (BMI). Because BMI does not capture abdominal fat distribution, adults with normal BMI but excess central adiposity may be overlooked despite having elevated hepatic risk. We examined the association of combined BMI-waist phenotypes with ultrasound-diagnosed FLD in a Chinese health examination population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cross-sectional study included 2,336 adults undergoing routine health examinations at the Health Examination Center of the Third People's Hospital of Chengdu, China. Participants were classified into four BMI-waist phenotypes: normal BMI\/no central obesity, normal BMI\/central obesity, overweight-obesity\/no central obesity, and overweight-obesity\/central obesity. The primary outcome was ultrasound-diagnosed FLD; moderate-to-severe steatosis was analyzed as a secondary outcome. Logistic regression models were fitted with sequential adjustment for major covariates. Additional analyses were conducted among adults with normal BMI, including a sensitivity analysis using waist-to-height ratio.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The overall prevalence of FLD was 28.3%. FLD prevalence increased across BMI-waist phenotypes, from 11.2% in the normal BMI\/no central obesity group to 27.8% in the normal BMI\/central obesity group, 27.9% in the overweight-obesity\/no central obesity group, and 51.5% in the overweight-obesity\/central obesity group. In the fully adjusted model, compared with the normal BMI\/no central obesity group, the odds ratios (ORs) for FLD were 2.46 (95% CI: 1.73\u20133.48) for normal BMI\/central obesity, 2.74 (95% CI: 2.01\u20133.72) for overweight-obesity\/no central obesity, and 6.78 (95% CI: 5.26\u20138.79) for overweight-obesity\/central obesity. Among adults with normal BMI, central obesity remained associated with FLD in the fully adjusted model (OR 2.48, 95% CI: 1.73\u20133.52). Similar patterns were observed for moderate-to-severe steatosis and in sensitivity analyses using waist-to-height ratio.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Central obesity was associated with higher observed odds of ultrasound-diagnosed FLD beyond BMI alone. These findings apply to etiology-agnostic ultrasound-detected fatty liver rather than MASLD\/MASH-specific disease and suggest that waist circumference may complement BMI in routine health examinations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1852073","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:29:51Z","timestamp":1782365391000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Beyond BMI: central obesity identifies overlooked fatty liver disease risk in adults with normal body mass index undergoing routine health examinations"],"prefix":"10.3389","volume":"14","author":[{"given":"Qingfeng","family":"He","sequence":"first","affiliation":[{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang","family":"Li","sequence":"additional","affiliation":[{"name":"Health Examination Center, The Third People's Hospital of Chengdu","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"He","sequence":"additional","affiliation":[{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiong","family":"Guo","sequence":"additional","affiliation":[{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"He","sequence":"additional","affiliation":[{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suiyuan","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Department of Pathology, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Luo","sequence":"additional","affiliation":[{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Department of Outpatient, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Zhu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Department of Pathology, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s00125-024-06196-3","article-title":"Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease","volume":"67","year":"2024","journal-title":"Diabetologia."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab."},{"key":"B6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1111\/jgh.15156","article-title":"Global epidemiology of lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"35","author":"Lu","year":"2020","journal-title":"J Gastroenterol Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/MCG.0000000000001270","article-title":"The Prevalence of lean\/nonobese nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"54","author":"Shi","year":"2020","journal-title":"J Clin Gastroenterol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.clnu.2018.08.008","article-title":"Lean non-alcoholic fatty liver disease","volume":"38","author":"Wang","year":"2019","journal-title":"Clin Nutr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"502","DOI":"10.14218\/JCTH.2022.00204","article-title":"Nonalcoholic fatty liver disease in lean\/nonobese and obese individuals: a comprehensive review on prevalence, pathogenesis, clinical outcomes, and treatment","volume":"11","author":"Patel","year":"2023","journal-title":"J Clin Transl Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1053\/j.gastro.2022.06.023","article-title":"Clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review","volume":"163","author":"Long","year":"2022","journal-title":"Gastroenterology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1159\/000521662","article-title":"Clinical profiles of Asians with NAFLD: a systematic review and meta-analysis","volume":"40","author":"Kam","year":"2022","journal-title":"Digestive diseases."},{"key":"B13","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jacc.2013.06.027","article-title":"Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality","volume":"62","author":"Britton","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1017\/S0029665113001249","article-title":"Ectopic fat, insulin resistance and non-alcoholic fatty liver disease","volume":"72","author":"Byrne","year":"2013","journal-title":"Proc Nutr Soc."},{"key":"B15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/cld.1183","article-title":"Nonalcoholic fatty liver disease: the role of visceral adipose tissue","volume":"19","author":"Hanlon","year":"2022","journal-title":"Clinical liver disease."},{"key":"B16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ajcn\/86.2.353","article-title":"Visceral adipose tissue accumulation differs according to ethnic background: results of the multicultural community health assessment trial","volume":"86","author":"Lear","year":"2007","journal-title":"M-CHAT."},{"key":"B17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S2213-8587(21)00045-0","article-title":"Epidemiology and determinants of obesity in China","volume":"9","author":"Pan","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","article-title":"Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR working group on visceral obesity","volume":"16","author":"Ross","year":"2020","journal-title":"Nat Rev Endocrinol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/met.2023.0114","article-title":"Combined effect of body mass index and waist circumference in predicting nonalcoholic fatty liver disease","volume":"21","author":"Lee","year":"2023","journal-title":"Metab Syndr Relat Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3748\/wjg.v21.i5.1650","article-title":"Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index","volume":"21","author":"Pang","year":"2015","journal-title":"World J Gastroenterol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12876-021-01782-w","article-title":"Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study","volume":"21","author":"Chen YL Li","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e056260","DOI":"10.1136\/bmjopen-2021-056260","article-title":"Li J, et al. Gender-specific prevalence of metabolic-associated fatty liver disease among government employees in Tianjin, China: a cross-sectional study","volume":"11","author":"Huang","year":"2021","journal-title":"BMJ open."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1127489","DOI":"10.3389\/fpubh.2023.1127489","article-title":"Prevalence of nonalcoholic fatty liver disease and the related risk factors among healthy adults: a cross-sectional study in Chongqing, China","volume":"11","author":"Kong","year":"2023","journal-title":"Front Public Health."},{"key":"B24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12944-021-01560-3","article-title":"Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in China","volume":"20","author":"Xie","year":"2021","journal-title":"Lipids Health Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology."},{"key":"B26","first-page":"83","article-title":"Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults\u2013study on optimal cut-off points of body mass index and waist circumference in Chinese adults","volume":"15","author":"Zhou","year":"2002","journal-title":"BES."},{"key":"B27","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.atherosclerosis.2008.03.001","article-title":"Optimal waist circumference cutoffs for abdominal obesity in Chinese","volume":"201","author":"Bao","year":"2008","journal-title":"Atherosclerosis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12916-014-0207-1","article-title":"proposal for a primary screening tool: \u2018Keep your waist circumference to less than half your height'","volume":"12","author":"Ashwell","year":"2014","journal-title":"BMC Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1053\/j.gastro.2025.02.044","article-title":"Global consensus recommendations for metabolic dysfunction-associated steatotic liver disease and steatohepatitis","volume":"169","author":"Younossi","year":"2025","journal-title":"Gastroenterology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"103043","DOI":"10.1016\/j.arcmed.2024.103043","article-title":"Global prevalence of nonalcoholic fatty liver disease: an updated review meta-analysis comprising a population of 78 million from 38 countries","volume":"55","author":"Amini-Salehi","year":"2024","journal-title":"Arch Med Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1097\/HEP.0000000000000696","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology."},{"key":"B33","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/1751-2980.12871","article-title":"Epidemiology of nonalcoholic fatty liver disease in non-obese populations: meta-analytic assessment of its prevalence, genetic, metabolic, and histological profiles","volume":"21","author":"Zou","year":"2020","journal-title":"J Dig Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1111\/j.1440-1746.2012.07222.x","article-title":"Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese","volume":"27","author":"Liu","year":"2012","journal-title":"J Gastroenterol Hepatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/0884533608321700","article-title":"Waist circumference measurement in clinical practice","volume":"23","author":"Ness-Abramof","year":"2008","journal-title":"Nutr Clin Pract."},{"key":"B36","doi-asserted-by":"publisher","first-page":"116116","DOI":"10.1016\/j.bcp.2024.116116","article-title":"The pathophysiology of visceral adipose tissues in cardiometabolic diseases","volume":"222","author":"Lee","year":"2024","journal-title":"Biochem Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","article-title":"as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk","volume":"34","author":"Ballestri","year":"2017","journal-title":"Adv Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"131528","DOI":"10.1155\/2015\/131528","article-title":"The influence of metabolic factors for nonalcoholic Fatty liver disease in women","volume":"2015","author":"Chung","year":"2015","journal-title":"Biomed Res Int."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1852073\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:29:52Z","timestamp":1782365392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1852073\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":40,"alternative-id":["10.3389\/fpubh.2026.1852073"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1852073","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"article-number":"1852073"}}